LDLR and Hypercholesterolemia: After specific modifications and highly efficient liver-specific LDLR gene expression, correction of hypercholesterolemia in LDLR deficient mice has no significant toxicity, thus providing another potential genetic tool for treating FH (Hou et al., 2016).